Haschke M - Search Results

1

Drug-related problems in hospitals: a review of the recent literature.

Krähenbühl-Melcher A, Schlienger R, Lampert M, Haschke M, Drewe J, Krähenbühl S. Krähenbühl-Melcher A, et al. Among authors: haschke m. Drug Saf. 2007;30(5):379-407. doi: 10.2165/00002018-200730050-00003. Drug Saf. 2007. PMID: 17472418 Review.

2

Drug-related problems in diabetes and transplant patients: an observational study with home visits.

Eichenberger PM, Haschke M, Lampert ML, Hersberger KE. Eichenberger PM, et al. Among authors: haschke m. Int J Clin Pharm. 2011 Oct;33(5):815-23. doi: 10.1007/s11096-011-9542-x. Epub 2011 Aug 3. Int J Clin Pharm. 2011. PMID: 21811831

3

Drug interactions and adverse events associated with antimycotic drugs used for invasive aspergillosis in hematopoietic SCT.

Egger SS, Meier S, Leu C, Christen S, Gratwohl A, Krähenbühl S, Haschke M. Egger SS, et al. Among authors: haschke m. Bone Marrow Transplant. 2010 Jul;45(7):1197-203. doi: 10.1038/bmt.2009.325. Epub 2009 Nov 30. Bone Marrow Transplant. 2010. PMID: 19946342

4

Retrospective analysis of adverse drug reactions leading to short-term emergency hospital readmission.

Banholzer S, Dunkelmann L, Haschke M, Derungs A, Exadaktylos A, Krähenbühl S, Liakoni E. Banholzer S, et al. Among authors: haschke m. Swiss Med Wkly. 2021 Jan 20;151:w20400. doi: 10.4414/smw.2021.20400. eCollection 2021 Jan 18. Swiss Med Wkly. 2021. PMID: 33516159 Free article.

5

Acute liver failure in two patients with regular alcohol consumption ingesting paracetamol at therapeutic dosage.

Krähenbuhl S, Brauchli Y, Kummer O, Bodmer M, Trendelenburg M, Drewe J, Haschke M. Krähenbuhl S, et al. Among authors: haschke m. Digestion. 2007;75(4):232-7. doi: 10.1159/000111032. Epub 2007 Nov 14. Digestion. 2007. PMID: 18004067

6

A study of the relationship between serum bile acids and propranolol pharmacokinetics and pharmacodynamics in patients with liver cirrhosis and in healthy controls.

Taegtmeyer AB, Haschke M, Tchambaz L, Buylaert M, Tschöpl M, Beuers U, Drewe J, Krähenbühl S. Taegtmeyer AB, et al. Among authors: haschke m. PLoS One. 2014 Jun 6;9(6):e97885. doi: 10.1371/journal.pone.0097885. eCollection 2014. PLoS One. 2014. PMID: 24906133 Free PMC article. Clinical Trial.

7

Hepatic veno-occlusive disease associated with immunosuppressive cyclophosphamide dosing and roxithromycin.

Beltinger J, Haschke M, Kaufmann P, Michot M, Terracciano L, Krähenbühl S. Beltinger J, et al. Among authors: haschke m. Ann Pharmacother. 2006 Apr;40(4):767-70. doi: 10.1345/aph.1G441. Epub 2006 Mar 7. Ann Pharmacother. 2006. PMID: 16595573

8

Pharmacokinetics of midazolam and metabolites in a patient with refractory status epilepticus treated with extraordinary doses of midazolam.

Bodmer M, Link B, Grignaschi N, Kummer O, Ruegg S, Haschke M, Krähenbühl S. Bodmer M, et al. Among authors: haschke m. Ther Drug Monit. 2008 Feb;30(1):120-4. doi: 10.1097/FTD.0b013e3181626ffd. Ther Drug Monit. 2008. PMID: 18223475

9

Pharmacokinetics and pharmacodynamics of sildenafil in a patient treated with human immunodeficiency virus protease inhibitors.

Aschmann YZ, Kummer O, Linka A, Wenk M, Azzola A, Bodmer M, Krähenbühl S, Haschke M. Aschmann YZ, et al. Among authors: haschke m. Ther Drug Monit. 2008 Feb;30(1):130-4. doi: 10.1097/FTD.0b013e318165ba71. Ther Drug Monit. 2008. PMID: 18223477

10

Pharmacokinetics and pharmacodynamics of quetiapine in a patient with a massive overdose.

Bodmer M, Burkard T, Kummer O, Beyrau R, Krähenbühl S, Haschke M. Bodmer M, et al. Among authors: haschke m. Ther Drug Monit. 2008 Aug;30(4):553-6. doi: 10.1097/FTD.0b013e31817fd5ed. Ther Drug Monit. 2008. PMID: 18641548

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

124 results

Search Page